NAIAD Drug Design

📍 São Caetano do Sul, Brazil🗓 Founded 2018👥 11 employees💰 Last funded Sep 2021
Biotechnology🌐 naiadd.com
Website LinkedIn
NAIAD is a drug discovery startup creating novel bioactive small molecules targeting G-protein coupled receptors (GPCRs). NAIAD’s computational simulation and deep learning based platform leverages structural biological information to virtually screen billions of molecules against specific GPCRs, looking for the ones that present the desired biological profile. The team of the company is composed of senior industry and academic researchers, biotech entrepreneurs and bioinformatics/chemoinformatics data scientists.. Our unique capabilities of protein motion sampling and ultra-high throughput virtual screening enable NAIAD to effectively search and screen a chemical space containing billions of molecules, hunting the ones with the highest potential of biological activity against the desired GPCRs, selecting the ones with the best pharmacodynamics and pharmacokinetics potential for further wet tests.
5
Total investors
4
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Brazil
5
Investor activity2018–2021 · investors recorded per year
2018420211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in NAIAD Drug Design?
NAIAD Drug Design has 5 investors on record on gritt.io, including 4 early-stage backers, 1 mid-stage.
When did NAIAD Drug Design last raise funding?
The most recent investment in NAIAD Drug Design recorded on gritt.io was in September 2021.
When was NAIAD Drug Design founded?
NAIAD Drug Design was founded in 2018.
What industry is NAIAD Drug Design in?
NAIAD Drug Design operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is NAIAD Drug Design based?
NAIAD Drug Design is headquartered in São Caetano do Sul, Brazil.